Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE INC

  • FDA Approval
  • Sept. 26, 2022, 09:20 UTC
  • 27
  • 0 comments

FDA approve RISANKIZUMAB-RZAA

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • Sept. 26, 2022, 09:14 UTC
  • 26
  • 0 comments

FDA approve NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE

Comment Full text

ALVOGEN

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 25
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 24
  • 0 comments

FDA approve TRAMADOL HYDROCHLORIDE

Comment Full text

ABBVIE INC

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 29
  • 0 comments

FDA approve RISANKIZUMAB-RZAA

Comment Full text

CELGENE

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 26
  • 0 comments

FDA approve AZACITIDINE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 22
  • 0 comments

FDA approve FLUOROURACIL

Comment Full text

DR REDDYS

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 24
  • 0 comments

FDA approve SUCCINYLCHOLINE CHLORIDE

Comment Full text

SANDOZ INC

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 26
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

SANDOZ INC

  • FDA Approval
  • Sept. 26, 2022, 01:41 UTC
  • 23
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text
  • Previous
  • 981
  • 982
  • 983
  • 984
  • 985
  • Next

Search

News categories

  • Technical Exchange News(12342)
  • Event(6229)
  • SEC News(271628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157991)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin